Atlas Trials

Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma

Clinical trial NCT01021800 · UNKNOWN

Trial details

NCT number
NCT01021800
Sponsor
Blood Transfusion Centre of Slovenia
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Tubular Adenocarcinoma
Start date
2009-04-01
Primary completion
2011-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.